文献速递睡眠呼吸障碍咽喉与嗓音

扁桃体切除术与改良悬雍垂腭咽成形术在扁桃体肥大伴阻塞性睡眠呼吸暂停患者中的有效性:TEAMUP随机临床试验

Effectiveness of Tonsillectomy vs Modified Uvulopalatopharyngoplasty in Patients With Tonsillar Hypertrophy and Obstructive Sleep Apnea: The TEAMUP Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

这项盲法随机临床试验在瑞典斯德哥尔摩一家大学医院比较改良悬雍垂腭咽成形术(mUPPP)与单纯扁桃体切除术(TE)治疗成人扁桃体肥大伴中重度阻塞性睡眠呼吸暂停(OSA)的效果。结果显示,mUPPP并不比单纯TE更有效,但TE在呼吸暂停低通气指数(AHI)上有小幅优势;由于单纯TE创伤更小,作者认为可考虑作为该特定患者群体的替代方案。

要点

  • mUPPP在改善AHI方面并不优于单纯TE。
  • AHI组间差异为9.2次/小时(95%CI 0.5-17.9),效应量小(Cohen d=0.44),方向有利于TE。
  • Epworth嗜睡量表(ESS)组间差异为1.1(95%CI -1.3至3.4;Cohen d=0.21),无临床相关性。

核心结论

  • mUPPP在治疗扁桃体肥大伴中重度OSA患者方面并不比单纯TE更有效。
  • 但存在小幅差异,方向有利于TE。
  • 由于单纯TE创伤更小,作者认为在该特定OSA患者群体中可考虑作为mUPPP的替代方案。

研究设计与样本

  • 盲法随机临床试验,比较mUPPP与单纯TE术前及术后6个月的效果。
  • 研究对象为扁桃体肥大(Friedman分期大小为2、3或4)伴中重度OSA的成人,来自瑞典斯德哥尔摩一家大学医院。
  • 患者于2016年1月至2021年2月接受手术,末次术后随访于2021年9月完成。
  • 研究队列共93例患者(平均[SD]年龄41.6[9.4]岁;80例[86%]为男性;未考虑种族/族裔),平均(SD)体重指数为29.0(2.8)。
  • 90例参与者(97%)完成方案(mUPPP组n=45;TE组n=45)。

主要发现

  • mUPPP组平均(SD)AHI评分从51.0(22.6)次/小时降至28.0(20.0)次/小时,降低43%。
  • TE组平均(SD)AHI评分从56.9(25.1)次/小时降至24.7(22.6)次/小时,降低56%。
  • AHI评分的平均组间差异为9.2次/小时(95%CI 0.5至17.9),效应量小(Cohen d=0.44),方向有利于TE。
  • ESS评分的组间差异也较小,仅为1.1(95%CI -1.3至3.4;Cohen d=0.21)。
  • 两种差异均未被认为具有临床相关性。

临床怎么用

  • 作者认为,由于单纯TE创伤更小,在该特定扁桃体肥大伴中重度OSA患者群体中可考虑作为mUPPP的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Modified uvulopalatopharyngoplasty (mUPPP) is a surgical treatment for selected adults with obstructive sleep apnea (OSA). Tonsillectomy (TE) alone is a less extensive alternative treatment. OBJECTIVE: To investigate whether mUPPP is more effective than TE alone in treating adult patients with tonsillar hypertrophy and moderate to severe OSA. DESIGN, SETTING, AND PARTICIPANTS: This blinded randomized clinical trial compared the effectiveness of mUPPP with TE alone before surgery and 6 months postsurgery in adults with tonsillar hypertrophy (sizes 2, 3, or 4 according to the Friedman staging) and moderate to severe OSA in a university hospital in Stockholm, Sweden. Participants underwent surgery from January 2016 to February 2021; the last postsurgery follow-up was completed in September 2021. Data analyses were performed from January to September 2022. INTERVENTIONS: mUPPP vs TE alone. MAIN OUTCOMES AND MEASURES: Between-group differences on the apnea-hypopnea index (AHI) and Epworth sleepiness scale (ESS). RESULTS: The study cohort comprised 93 patients (mean [SD] age, 41.6 [9.4] years; 80 [86%] men; race/ethnicity were not considered) with a mean (SD) body mass index of 29.0 (2.8), calculated as weight in kg divided by height in m2. Of these, 90 participants (97%) completed the protocol (mUPPP, n = 45; TE, n = 45). The mean (SD) AHI score (number of events per hour [events/h]) for the mUPPP group decreased by 43%, from 51.0 (22.6) to 28.0 (20.0) events/h; and for the TE group, 56%, from 56.9 (25.1) to 24.7 (22.6) events/h. The mean between-group difference in AHI score was 9.2 events/h (95% CI, 0.5 to 17.9), with a small effect size (Cohen d = 0.44) in favor of TE. For ESS scores, the between-group difference was also small, only 1.1 (95% CI, -1.3 to 3.4; Cohen d = 0.21). Neither difference was considered to be clinically relevant. CONCLUSIONS AND RELEVANCE: This randomized clinical trial demonstrated that mUPPP was not more effective than TE alone in treating patients with tonsillar hypertrophy and moderate to severe OSA. However, there was a small difference in favor of TE. Because TE alone is less extensive, it could be considered as an alternative to mUPPP in this selected group of patients with OSA. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02523248.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Sundman J, Nerfeldt P, Fehrm J, et al. Effectiveness of Tonsillectomy vs Modified Uvulopalatopharyngoplasty in Patients With Tonsillar Hypertrophy and Obstructive Sleep Apnea: The TEAMUP Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 36326742. doi:10.1001/jamaoto.2022.3432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。